REVB
NASDAQ · Biotechnology
Revelation Biosciences Inc
$1.65
+0.18 (+12.24%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 725.2K | 710.5K | 685.3K |
| Net Income | -167,658 | -204,058 | -214,742 |
| EPS | — | — | — |
| Profit Margin | -23.1% | -28.7% | -31.3% |
| Rev Growth | -8.8% | +0.9% | +1.6% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 1.22M | 1.04M | 1.16M |
| Total Equity | 1.60M | 1.66M | 1.64M |
| D/E Ratio | 0.76 | 0.62 | 0.70 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | -214,609 | -243,655 | -229,479 |
| Free Cash Flow | -113,026 | -111,014 | -146,791 |